Original Contribution |
From the Second Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Correspondence to Masayoshi Soma, MD, PhD, Second Department of Internal Medicine, Nihon University School of Medicine, 30-1 Ooyaguchi-kamimachi, Itabashi-ku, Tokyo 173, Japan. E-mail msoma{at}med.nihon-u.ac.jp
AbstractThe
natriuretic peptide (NP) system may play a crucial role in
development of essential hypertension (EH). C-type NP dilates arteries
and lowers blood pressure and inhibits proliferation of vascular smooth
muscle cells via the type B NP receptor (NPR-B). However, the
association of the human NPR-B gene with EH has not been studied,
because little is known about the genomic organization of this gene. We
designed oligonucleotide primers based on the cDNA
sequence of the human NPR-B gene, and long-range polymerase chain
reaction (PCR) was performed. The amplified fragments were sequenced
directly, and the exon/intron organization of the human NPR-B gene was
determined. The gene, which spans
16.5 kbp, is composed of 22 exons,
and the intron-exon junctions follow the GT-AG rule. Seven hundred
fifty base pairs of the 5'-flanking region were sequenced using a
thermal asymmetric interlacedPCR (TAIL-PCR) method. This region
contains 10 potential Sp1 binding sites and lacks a TATA box. Rapid
amplification of cDNA ends (RACE) revealed the transcriptional start
site at -14 bp. A CA/GT microsatellite repeat was identified with a
hybridization-based method and was converted to a sequence-tagged site
(STS). The GT microsatellite repeat was localized to intron 2
150 bp
downstream of the exon-intron junction. Two alleles, (GT)10 and
(GT)11, were detected in both EH patients and age-matched normotensive
(NT) controls. Multiple logistic linear regression analysis
indicated that the NPR-B genotype is associated significantly
with EH (odds ratio 1.55; 95% confidence interval, 1.02 to 2.35). The
(GT)11 frequency was 0.316 (65/206) for the EH group and 0.218 (44/202)
for the NT group and differed significantly between the EH and NT
groups (
2=4.97, P=0.026). The structural
organization of the human NPR-B gene was determined, and a novel GT
repeat polymorphism, which associated with EH, was identified.
These results suggest that one cause of EH is a mutation in this gene
or a closely related gene or region.
Key Words: natriuretic peptide receptor, type B gene structure association essential hypertension
This article has been cited by other articles:
![]() |
H. A. Ghofrani, R. J. Barst, R. L. Benza, H. C. Champion, K. A. Fagan, F. Grimminger, M. Humbert, G. Simonneau, D. J. Stewart, C. Ventura, et al. Future perspectives for the treatment of pulmonary arterial hypertension. J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S108 - S117. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vassalle and M. G. Andreassi Genetic Polymorphisms of the Natriuretic Peptide System in the Pathogenesis of Cardiovascular Disease: What Lies on the Horizon? Clin. Chem., May 1, 2009; 55(5): 878 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Hume, J. Buttgereit, A. M. Al-Awadhi, S. S. Al-Suwaidi, A. John, M. Bader, M. C. Seabra, L. Al-Gazali, and B. R. Ali Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux Hum. Mol. Genet., January 15, 2009; 18(2): 267 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Potter, S. Abbey-Hosch, and D. M. Dickey Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions Endocr. Rev., February 1, 2006; 27(1): 47 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tamura, L. K. Doolittle, R. E. Hammer, J. M. Shelton, J. A. Richardson, and D. L. Garbers Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs PNAS, December 7, 2004; 101(49): 17300 - 17305. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rahmutula, J. Cui, S. Chen, and D. G. Gardner Transcriptional Regulation of Type B Human Natriuretic Peptide Receptor Gene Promoter: Dependence on Sp1 Hypertension, September 1, 2004; 44(3): 283 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Langenickel, J. Buttgereit, I. Pagel, R. Dietz, R. Willenbrock, and M. Bader Forced Homodimerization by Site-Directed Mutagenesis Alters Guanylyl Cyclase Activity of Natriuretic Peptide Receptor B Hypertension, February 1, 2004; 43(2): 460 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Lucas, G. M. Pitari, S. Kazerounian, I. Ruiz-Stewart, J. Park, S. Schulz, K. P. Chepenik, and S. A. Waldman Guanylyl Cyclases and Signaling by Cyclic GMP Pharmacol. Rev., September 1, 2000; 52(3): 375 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakayama, M. Soma, Y. Takahashi, D. Rehemudula, K. Kanmatsuse, and K. Furuya Functional Deletion Mutation of the 5'-Flanking Region of Type A Human Natriuretic Peptide Receptor Gene and Its Association With Essential Hypertension and Left Ventricular Hypertrophy in the Japanese Circ. Res., April 28, 2000; 86(8): 841 - 845. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |